A new study indicates that the diabetes drug Lantus is no more likely to cause diabetic retinopathy than insulin. The 5-year study on Lantus versus NPH insulin showed similar rates of safety and retinopathy in both groups, despite an earlier study which linked Lantus to the eye disease.
Read full story >